LifeTech Reports Steady Growth of 32.5percent in Net Profit

SHENZHEN, China, March 29, 2023 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results. During the year ended 31 December 2022, Lifetech achieved a revenue of approximately RMB1,097.3 million, increased by 18.6% year on year. The...

Related Keywords

China , Shenzhen , Guangdong , United States , Japan , Bankura , Ankara , Turkey , , Aortic Branch Stent Graft System , Aortic Arch Branch Stent Graft System , Adult Congenital Heart Disease Center , Lifetech Scientific Corporation , Ministry Of Food , Lifetech Scientific Corporation Stock Code , National Medical Products Administration , Drug Administration For Compassionate , Showa University Hospital , Lifetech Scientific Corporation The Company Or , Left Atrial Appendage , Congenital Heart Diseases , Vena Cava Filter System , Balloon Dilatation Catheter , Stent Graft System , Absorbable Atrial Septal Defect Closure System , Sizing Balloon , Arch Stent Graft System , Plus Aortic Arch Stent Graft System , Chimney Aortic Stent Graft System , Pro Aortic Stent Graft System , Endovascular Needle System , Thoracoabdominal Artery Stent Graft System , Iron Bioresorbable Scaffold System , Drug Administration , Prospective Multicenter Single Arm Target Study , Concave Supra Arch , Ventricular Septal Defect Occluder , Pediatric Heart Disease , Stock Code ,